MIRM — Mirum Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1759425 ·
Last close
$89.70
Market Cap
$5.82B
52W High
$130.00
52W Low
$63.23
ADV30
614,130
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 176,243,000 | 145,895,000 | -26,102,000 | -67,227,000 | 1,044,981,000 | 330,728,000 | 1,055,403,000 |
| Mar 2026 | 159,882,000 | 131,077,000 | -63,163,000 | -790,155,000 | 890,916,000 | 324,907,000 | 648,422,000 |
| Dec 2025 | 148,932,000 | 120,668,000 | -4,567,000 | -5,730,000 | 842,813,000 | 296,683,000 | 528,123,000 |
| Sep 2025 | 133,010,000 | 107,473,000 | 2,603,000 | 2,905,000 | 785,115,000 | 282,021,000 | 493,069,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-227,267,000
Investing CF
$-172,781,000
Financing CF
$506,612,000
CapEx
$-36,474,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-14.55
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,524,926,000
Inventory
$25,769,000
Receivables
$145,360,000
ST Investments
$107,563,000
EBIT TTM
$-844,100,000
Pretax Income TTM
$-857,538,000
Interest Exp TTM
$13,438,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$618,067,008
EBITDA
$-70,283,000
Free Cash Flow
$76,618,128
Enterprise Value
$6,702,299,136
Total Cash
$438,291,008
Total Debt
$762,948,992
Shares Out
64,932,203
Trailing EPS
$-14.08
Book Value
$-0.16
ROE
-703.0%
ROA
-6.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 521,312,000 | -22,136,000 | -23,363,000 | 842,813,000 | 528,123,000 | 314,690,000 | 55,827,000 |
| Dec 2024 | 336,888,000 | -87,606,000 | -87,942,000 | 670,754,000 | 445,114,000 | 225,640,000 | 10,325,000 |
| Dec 2023 | 186,374,000 | -109,154,000 | -163,415,000 | 646,621,000 | 397,951,000 | 248,670,000 | -70,944,000 |
| Dec 2022 | 77,062,000 | -131,220,000 | -135,665,000 | 352,906,000 | 210,869,000 | 142,037,000 | -120,136,000 |
TTM Snapshot
Revenues TTM
$249,687,000
NetIncome TTM
$-52,500,000
OpCashFlow TTM
$0
Assets (Latest)
$842,813,000
Forward EPS
$-0.35
Max Pain — expiry 2026-12-18
max pain strike: $85.00 · spot: $85.39 · call oi: 1,188 · put oi: 472Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | $6.01B | $301.52 | — |
| COGT | Cogent Biosciences, Inc. | $5.61B | $32.31 | — |
| TVTX | Travere Therapeutics, Inc. | $5.60B | $59.44 | — |
| ORKA | Oruka Therapeutics, Inc. | $5.59B | $84.46 | — |
| LQDA | Liquidia Corp | $6.13B | $68.43 | — |
News headlines (Yahoo Finance, 1h cache)
Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment
2026-09-28 12:38 · Yahoo
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
2026-09-28 12:00 · Yahoo
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
2026-09-27 21:00 · Yahoo
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
2026-09-25 23:00 · Yahoo
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill
2026-09-25 18:43 · Yahoo
FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week
2026-09-21 11:06 · Yahoo
MIRM, INCY Stocks In Focus — Will A September 26 FDA Ruling Reward This Week’s Gains?
2026-09-17 22:44 · Yahoo
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-14 20:01 · Yahoo
Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
2026-09-08 12:30 · Yahoo
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
2026-09-02 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.